1-13 of 13
Christian Jacques
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rationale for and Design of Papilio-1: A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Feasibility, Safety, and Efficacy of Point-of-Care-Manufactured Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells (GLPG5301) in Relapsed/Refractory Multiple Myeloma

Niels W.C.J. van de Donk, Sébastien Anguille, Jo Caers, Marte C. Liefaard, Christian Jacques, Anna D.D. van Muyden
Journal: Blood
Blood (2023) 142 (Supplement 1): 4859.
https://doi.org/10.1182/blood-2023-189001
Published: 2023
Journal Articles

Initial Clinical Results of Atalanta-1, a Phase I/II Trial of Point-of-Care Manufactured GLPG5102 (19CP02) in RR NHL

Sébastien Anguille, Ilse Kuipers, Kirsten Saevels, Yves Beguin, Anna Van Muyden, Christian Jacques, Marie Jose Kersten
Journal: Blood
Blood (2022) 140 (Supplement 1): 10323–10324.
https://doi.org/10.1182/blood-2022-163830
Published: 2022
Journal Articles

The OP-104 Anchor Study: A Phase 1/2 Study of Safety and Efficacy of Melflufen and Dexamethasone in Combination with Either Bortezomib or Daratumumab in Patients with Rrmm; First Report on Phase 1 Data

Ludek Pour, MD, Miquel Granell, MD, Roman Hajek, MD PhD, Albert Oriol, MD, Yvonne Efebera, MD, Jacques Delaunay, MD, Katell Le Du, MD, Jean-Richard Eveillard, MD, Lionel Karlin, MD, Vladimir Maisnar, MD, Joaquin Martinez Lopez, MD, Maria-Victoria Mateos, MD PhD, Jan Moreb, MD, Vincent Ribrag, MD, Paul Richardson, Jan Straub, MD, Catriona Byrne, RN, Christian Jacques, MD, Hanan Zubair, MSc, Enrique Ocio, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1967.
https://doi.org/10.1182/blood-2018-99-112983
Published: 2018
Journal Articles

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability of Pomalidomide + Low-Dose Dexamethasone in Patients with Relapsed or Refractory and Refractory Multiple Myeloma and Renal Impairment

Jeffrey Matous, MD, David S Siegel, MD PhD, Sagar Lonial, MD, R. Donald Harvey, PharmD, Claudia Kasserra, PhD, Yan Li, PhD, Min Chen, PhD, Thomas Doerr, MSc, Lars Sternas, MD, Mohamed H. Zaki, MD, Christian Jacques, MD, Jatin J. Shah, MD
Journal: Blood
Blood (2014) 124 (21): 4730.
https://doi.org/10.1182/blood.V124.21.4730.4730
Published: 2014
Journal Articles

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

Clinical Trials & Observations
Paul G. Richardson, David S. Siegel, Ravi Vij, Craig C. Hofmeister, Rachid Baz, Sundar Jagannath, Christine Chen, Sagar Lonial, Andrzej Jakubowiak, Nizar Bahlis, Kevin Song, Andrew Belch, Noopur Raje, Chaim Shustik, Suzanne Lentzsch, Martha Lacy, Joseph Mikhael, Jeffrey Matous, David Vesole, Min Chen, Mohamed H. Zaki, Christian Jacques, Zhinuan Yu, Kenneth C. Anderson
Journal: Blood
Blood (2014) 123 (12): 1826–1832.
https://doi.org/10.1182/blood-2013-11-538835
Published: 2014
Journal Articles

MM-003 Phase 3 Study Of Pomalidomide In Combination With Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM): POM + Lodex Is Beneficial For Elderly Patients (> 65 Years of Age)

Katja Weisel, MD, Jesús F. San Miguel, MD, PhD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Stefan Knop, MD, Xin Yu, PhD, Latisha Watkins, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2013) 122 (21): 3198.
https://doi.org/10.1182/blood.V122.21.3198.3198
Published: 2013
Journal Articles

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability Of Pomalidomide + Low-Dose Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment

Jeffrey Matous, MD, David S. Siegel, MD, PhD, Hien K. Duong, MD, Claudia Kasserra, PhD, Min Chen, PhD, Thomas Doerr, MSc, Lars Sternas, MD, Mohamed H. Zaki, MD, PhD, Christian Jacques, MD, Jatin J. Shah, M.D.
Journal: Blood
Blood (2013) 122 (21): 5393.
https://doi.org/10.1182/blood.V122.21.5393.5393
Published: 2013
Journal Articles

Patient Outcomes By Prior Therapies and Depth Of Response: Analysis Of MM-003, a Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)

Jesús F. San Miguel, MD, PhD, Katja Weisel, MD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Christoph Renner, MD, Nizar J. Bahlis, MD, Xin Yu, PhD, Terri Teasdale, MS, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2013) 122 (21): 686.
https://doi.org/10.1182/blood.V122.21.686.686
Published: 2013
Journal Articles

Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)

Meletios A. Dimopoulos, MD, Katja Weisel, MD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Andrew Spencer, MD, Stefan Knop, MD, Nizar J. Bahlis, MD, Christoph Renner, MD, Xin Yu, PhD, Kevin Hong, MS, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Jesús F. San Miguel, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 408.
https://doi.org/10.1182/blood.V122.21.408.408
Published: 2013
Journal Articles

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Clinical Trials & Observations
Paul G. Richardson, David Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Jacob Laubach, Daniel Sullivan, Melissa Alsina, Robert Schlossman, Irene M. Ghobrial, Deborah Doss, Nora Loughney, Laura McBride, Elizabeth Bilotti, Palka Anand, Lisa Nardelli, Sandra Wear, Gail Larkins, Min Chen, Mohamad H. Zaki, Christian Jacques, Kenneth C. Anderson
Journal: Blood
Blood (2013) 121 (11): 1961–1967.
https://doi.org/10.1182/blood-2012-08-450742
Published: 2013
Journal Articles

Simulation of Clinical Outcome for Pomalidomide Plus Low-Dose Dexamethasone in Patients with Refractory Multiple Myeloma Based on Week 8 M-Protein Response

Rene Bruno, PhD, Fredrik Jonsson, PhD, Mohamed Zaki, MD, PhD, Christian Jacques, MD, Arlene S Swern, PhD, Paul G. Richardson, MD, Vincent Rajkumar, MD, Laurent Claret, PhD
Journal: Blood
Blood (2011) 118 (21): 1881.
https://doi.org/10.1182/blood.V118.21.1881.1881
Published: 2011
Journal Articles

A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib.

Paul Richardson, David Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Daniel Sullivan, Laura McBride, Deborah Doss, Gail Larkins, Christian Jacques, Arlene Donaldson, Kenneth C. Anderson
Journal: Blood
Blood (2009) 114 (22): 301.
https://doi.org/10.1182/blood.V114.22.301.301
Published: 2009
Journal Articles

A Phase III Study to Determine the Efficacy and Safety of Lenalidomide in Combination with Melphalan and Prednisone (MPR) in Elderly Patients with Newly Diagnosed Multiple Myeloma.

Antonio Palumbo, Meletios A. Dimopoulos, Michel Delforge, Martin Kropff, Robin Foa, Zhinuan Yu, Lindsay Herbein, Jay Mei, Christian Jacques, John Catalano
Journal: Blood
Blood (2009) 114 (22): 613.
https://doi.org/10.1182/blood.V114.22.613.613
Published: 2009